Skip to main content Skip to section navigation Skip to footer
Aethlon Medical, Inc.
  • Home
  • The Hemopurifier®
    • Overview
    • The Hemopurifier® in Cancer
    • The Hemopurifier® in Infectious Disease
  • About
    • Overview
    • Executive Team
    • Board of Directors
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Publications
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Analyst Coverage
  • Contact Us
Investors
  • Overview
  • Corporate News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Executive Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
    • IRS Form 8937
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Governance Documents
  • Analyst Coverage

Press Releases

  • Corporate News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Oct 7, 2019

Aethlon Medical Announces FDA Approval Of IDE For Oncology Indications

Oct 3, 2019

Aethlon Medical Receives Extension from Nasdaq to Regain Compliance with Continued Listing Requirements

Sep 24, 2019

Aethlon Announces Collaboration to Identify Exosomes Involved in Cancer Progression and Treatment Resistance

Sep 16, 2019

Aethlon Medical Receives National Cancer Institute Contract Award

Aug 14, 2019

Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

Aug 7, 2019

Aethlon Medical To Release First Quarter Financial Results and Host Conference Call on August 14, 2019

Jul 1, 2019

Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update

Jul 1, 2019

Aethlon Medical, Inc. and SeaStar Medical, Inc. Announce Strategic Joint Cross-Licensing Agreement

Jun 19, 2019

Aethlon Medical To Release Fiscal Year End Financial Results and Host Conference Call on July 1, 2019

May 13, 2019

Aethlon Medical Announces Collaboration With Prostate On-Site Project (POP), Host Of The Jerry Colangelo Sports Legend Golf Classic, To Engage With Participants For CTE Studies

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • …
  • Page 23
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Linkedin
Privacy Policy Disclaimer Sitemap Accessibility Statement
©2023 Aethlon Medical, Inc. All Rights Reserved.